Dec 08, 2021 / 03:00PM GMT
Operator
Good morning. My name is Sia, and I will be the conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics Virtual Investor Day. (Operator Instructions) As a reminder, today's call is being recorded.
I would now like to turn the call over to Jason Finkelstein of Argot Partners. Jason?
Jason Finkelstein -
Good morning, everyone, and thank you all for joining us today for Karyopharm Therapeutics Investor Day. My name is Jason Finkelstein and my firm, Argot Partners handles Investor Relations for Karyopharm. Immediately following our call today, the slides that are being presented will be made available on the Investor Relations section of Karyopharm's website.
Before we begin, I'd like to remind you that various remarks we will make today constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995 as outlined on Slide 2. These include statements about our future expectations, clinical developments and regulatory matters and time
Karyopharm Therapeutics Inc Virtual Investor Day Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot